Get startedLog in
    Picture of Pacira BioSciences logo

    PCRX — Pacira BioSciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapSuper Stock
    All News

    Brief: Pacira BioSciences Concludes Patient Enrollment in Part A of Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee

    Picture of Pacira BioSciences logoPacira BioSciences
    05/11/2025 13:41
    Nov 5 (Reuters) - Pacira Biosciences Inc PCRX.O:

PACIRA BIOSCIENCES CONCLUDES PATIENT ENROLLMENT IN PART A OF PHASE 2 STUDY EVALUATING SAFETY AND EFFICACY OF PCRX-201 FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE

Source text: ID:nGNX3PnPwm

Further company coverage: PCRX.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Pacira BioSciences

    See all news